ALNLF — Neolife SA Income Statement
0.000.00%
Last trade - 00:00
- €5.88m
- €6.32m
- €12.85m
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.31 | 7.83 | 10.7 | 13.4 | 12.8 |
Cost of Revenue | |||||
Gross Profit | 2.29 | 2.44 | 1.86 | 1.6 | 1.73 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.07 | 8.19 | 11.1 | 17.4 | 13.5 |
Operating Profit | -0.76 | -0.356 | -0.333 | -4.05 | -0.606 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.813 | -0.408 | -0.368 | -3.66 | -0.631 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.931 | -0.516 | -0.304 | -3.62 | -0.524 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.931 | -0.516 | -0.304 | -3.62 | -0.524 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.931 | -0.516 | -0.304 | -3.62 | -0.524 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.018 | -0.01 | -0.005 | -0.017 | -0.005 |
Dividends per Share |